Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder

NCT04847245 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Chronic Visceral Pain
Major Depressive Disorder

Interventions

DRUG: Pregabalin 75mg tid + Duloxetine
DRUG: Intravenous administration of esketamine 0.125 mg/kg+Duloxetine
DRUG: Intravenous administration of esketamine 0.25 mg/kg +Duloxetine
DRUG: Intravenous administration of esketamine 0.50 mg/kg+Duloxetine

Sponsor

Peking University